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,,irr I,,, Il’c,, )r,,* 
H,,xrle”,iro diohctir ,a,, dnclop 0 c”rdi”my”palh) ~haracler- 
irvd by ry,,“,ic il”d diU,,“,iC re”lrit”lar dysf”“clian, myocnrdial 
hyp+r,r”pby and tibr”&. p”tm”“ary cungesli”” and a very high 
m”rt”li,g rale. Alterations in runtractile pruleins and urcoplar- 
mir re,ic”t”r c”Ici”m (Ca”) lranrport in diabetic mywardium 
and Lhdr partial rewrw, rilh “erepsmit u&es, Lha, calrium 
&n”ct bt”&adr may ,,rwm, death fr”rum c”“~e~,ivr hiiart L,,“rc 
in hwerlcnrivu diabetic rats. 
A llrle group “f rats with ren”wwt”r h)perta”slon and 
rlrcp,o~“,“cin diabsls were dividrd in,” fuur grwp: “ntnrt~d 
““imah Gr”“” II and mim”ts lreutrd wilh 100 Grow 11. SUO 
Gruup 3) or 6tm Gruup 4, mgkg per day of .wtainbd retearl 
diltiarem mired in ,heir fuud. Trea,mu”, was beg”” sbortty “Lr 
thz ““ret “l br”ert”nsi”” “nd dirbetu. M”rt”litv rates after 4 
monlh, uere 5% (tY”l32,. 53% (17 “P32,. 27, (7 “l26, and 
35% 111~131, in Gra”ps I, 2, J and 4. r~~~ctt~ety; ,he m”rtati,y 
ra,e in age-m&bed c”“,r”t ra,s w”s 5% tt “P 19,. The reduai”“, 
in m”r,alit> rate, in Craupr 3 and 4 were s,ati~,tcatl~ ripnitlcant. 
“itli”dI”l did not <hnnge ,yr,olic h,o”d prerwre, Se,“,” g,u- 
C”II N”PL”,rati”“, he&w, rsfC or Ien Ye”friCYtsr Olass. There was 
a (rend t” decread IeR venlricul”r interstitial Gbr& sod 
privrzular fibrosis in diltiwm.lreated animals. Venlriculnr 
cotlsge” c”“ce”,rati”” was similar in ““treated hyprtesi~e 
dinbetic and c”“,r”t rats; tcwts were tdg!w in hypurtemive 
diab&c r”ts lb”, died than in ,h”v lha, urvived. There wps a 
Irend t” derrrwd c”II”g.en c”ncrntrs,i”n as d&rem d”se in- 
creased. 
Myain iwniyme dtstrtbuttun was nM changed in Cmups S 
and 4 (in cumpariwn with tiroup It. In a,l hypertensive dtabettc 
group% r?ts that died had a higher bled pressure, heart rate, 
retatiw left wntricular ma% t”:u wilt and t”w water than did 
survivors. The murtslit~ rate w&two lothree tin,& highernmwg 
rat” with an inilial btwd presrwe 2180 mm Hg. The be&&d 
etIec,s “l dittianem “” rurrirst were mm, signitir”“, among raw 
with were hyprtcnsion. 
Dzehc,c\ omclliub II a\socia,cd with “” incrcarrd frequency 
“fc”nge6c hart Lilurc independent of coronrry “thcro- 
~ICIOII~ (1.2). Several studier (3.4) have shown the1 hyper- 
lenrive dkbelic pakdr are at cspecidly high rlrk for 
dcvclopmen, of ” cardiomyopathy. Experimcn,al atudiea 
V-11 hat I;ogclyf”cu~ed”nnurmo,unrivc diahcricanimal\. 
Uerpilcevidencc of\y\,“lic “rdi.s*,ubc vcn,riculardysf”nc- 
tion. “I both. I” ,hcx studies. clinicully evident cong+u 
herrI Mure (with awciawd death) did not develop. a, leart 
over the time frame studied. Cunacquently. scvcral recent 
rludle> IX-131 hwe chnmmcd imyuwd,dl function. S,RF,U~ 
and bwcbcm~nr) I” byponcnwc diabetic ra, In cornpar,. 
son with rd,\ will, diahc,“~ idunc. ra *i,h i!,i combined 
diwdcr hiw a high rrwnality rate. wlch evvlence “f circu- 
l”lwy congestion and increawd myocnrdiul fihroG, in thow 
“kerations in pspillary muscle fun&n. elcctrophysiology. 
myoci,rdial histopathulogy and contractile protein biochem- 
ist, y in ,ab with combined hypertension and diabetes are a, 
leaat as tgut and in many instances greater than thoar in rats 
wirh hypertension “lone or diabetes alone. Howevo. i, 
remains unclear which processes “re rerpons.bie for ,he 
dcvclupmcot nrf conp6l: huan failure and death in this 
mudcl. 
Despite these uncervaintieb. aeverul experimental findings 
in diabetic and hypenunaive diilbclic rills suggest rha, cal- 
cium channel bluckera may he useful in prevendng or 
waling lhis dirordcr. I)i”betc\ is aa”cia,cd wilh al,er”,i”n~ 
in a varie,y of diffcrcnt calcium twnaport pr”cesscs in r&t 
myocardium (14-171. ;‘utahle among these is decreued 
ulcium uptake by iwlatvd wcoplasmic reticulum. which 
msy ~~cc”u”, for alowing of myucardial rclawion (14.15). I, 
IS powbte tha, rucb chsngca ~csub in myucwdial calcium 
ovurhxad. ‘Thor is au~gesed by ,h” ubacrvati”” ,18,lY) lha, 
piepillary muscle from diabc,ic ra,s exhibits a greater degree 
of contractwe. a greater drgree of action putenfiill shorten- 
ing and a grrilter number al delayed afterdepolarizations on 
exposure fo d,givel,s or increwd exitrwllular calcium. The 
i . 
when gvu,, ,n rhe dnnkmg .uater lo achieve mnrc nearly 
contmuw~ xlminhration of the drug. diltiarem was unwc- 
uexxful hcc.!u?c of its bitter !;tcte Cardircm SR head< proved 
ideal bCCaU%e encapsularion both eliminatLd Ihc ta\tc proh- 
lem and prnlongcd the duratton oiactlon. Frcqucnl eating hy 
ihu nrtx IW\ alw believed to contrihutc 10 maintaining nearly 
comiimt drug levcI\. Rats that were to receive IW or 
3N mplkgperday ofdillwem(Groupr 2and 3,recpectively) 
sarlcd lrealment at these dose\. Rats that were 10 receive 
I.1H) mglkk per day ofdiltiezem began freatmcnt with adose 
of 300 mglkg per day thal was mcreascd to MM mgikg per dny 
ancr 6 days and furlher increased 10 I.200 mplkg per day 
after anorhel 8 day?. Pwhminary srudies (I;a;pu$ihcd data, 
Fcin FS) wggead that I.?00 mglkg per day war loleraled 
by hyperwnrivc diabelic rats. In the present study. however, 
body weight declined sigmficandy within 3 days of the qtan 
of Ihis dov. To avoid drug.related death. the dose in Group 
4 wa\ decreased 10 600 meike DCT dav (rhc rats with Ihe 
grealcsl decrease in body-&h1 hai their dose briefly 
lowered 10 300 mg/kg per day and subsequently mcreased 10 
MO me/kg per day). No deaths occurred in Group 4 during 
lhir period of dose adjuatmenl. 
Hlood presrure and hear! rale were monhored about 
twcc it month in hyperlensive diabetic rats and once every 2 
months in comrol rats aRer diltiarem therapy WI started. 
When an animal died spontaneously. hs hear< was blatted 
dry and weighed after the great vessels and atria were 
trimmed and the right and lefl ventricles were separated and 
weighed (includmg rhc inlcrvcntricular sepun with Ihe left 
wwriclcl. Aboul400 mg of left ventricle and IO0 mg of right 
venlricle were preserved in 10% buffered formahn for his. 
tokxic studv and collaeen determination. Wet weiehts ofthc 
Iun& liverand kidney; wcrc also ohlamed: 200 lo-300 mgof 
lung was dried a, 80°C in an oven 10 delermine the level of 
slarl of ddtiazem therapy. when survival curve analysis 
showed a beneficial effect of the drug. all survivine. rats were 
killed. In general, the protocol al the time of indiced death 
was the same a$ that for animals that died soontaneousl~ 
with Ihe addition of II blood sampling for dc&mination if 
serum glucose concentration and in a subgroup, for deter- 
mination of plasma levels of diltiazem and twomelaboliles: 
and 2) placemenl of IWmg samples of left ventricle (apex Lo 
base slices) in a buffer-d 50% glycerol solulion at -WC for 
subsequent analysis. A subgroup of survivhw hvsertensive 
diahelic and comrol rats aIs; underwent coro&pafusion 
with Microril as described previously: analvsis of the mi- 
crovaxulature of these he& is not compleleand will not be 
reponcd in Lhe Present study 122). This subgroup includes 
six r&s from each of the rive groups except Group 2. in 
which five hearts were studied in this way. Routine cardiac 
palhologic findings and ventricular weights of these hearts 
are nor included in the Rcsuks. In addition. collagen dew- 
mination and conlraaile prowin studies were not performed 
on Microfil-perfused hearts. 
Mvocardial structural studios. All tissues for nmholoeic 
evah&on were studled wirhout knowledge of the animal 
stalus (SC. a,ld S.M.F.). Two transverse midvenlricular 
rings of lefl venlricular tissue and one ring of righl ventric. 
ular tissue were placed in 3.7% formaldehyde in phosphate- 
buRred saline solution. Left and righl venlricdar rings were 
seclianed. par&in embedded and stained with hematoxylin- 
eocin. Pathologic changes within each ring. including intcrsli- 
tml fibrosis, perivascular fibrosis and vascular sclerosis. were 
evaluated semiquandfativcly: absent (grade 0). mild Igrade I). 
moderate (grade 2) and severe (grdde 31. Interslhial fibrosis is 
scar tissue presem between viable myocytes. Perivascalar 
fibrosis is s&r tissue around vc~sels &tending into the sur- 
rounding myocardium. Vaxular sclerosis is thickening and 
scaning of the veccel wall with lumen narrowing. 
Myoeardial collagen s(udies. Paraffin-cmbcdded tissue 
blocks were recut Lo make ussue seelinnr IO pm in thickness 
(containing seclions of both ventricles on each slide) and 
these were analyzed for micrograms of collagen content per 
milligram of protein according 10 rhc method of Lolrcr-de 
Leon and Rojkind (24). In brief. tissues were depar&ized 
and stained for 30 min with a mixture of Sirius red F3BA and 
Psi green FCF in saturated picnic acid. After numerous 
water washings, the stain was elated from the tissue with 
2 ml of 0.1 N of sodium hydmxide (NaDH) in absolute 
methanol II: I volume/volume mixture) and the optical den- 
sity of the eluted color was read immediately in e Perkin- 
Elmer 559A specrmpholomeler at 605 and ?40 nm. the 
respective maximal absorbency wavelengths of fad preen 
FCF and Sirius red F3BA. ~w~grarn~ of collagen per 
milligram of noncollagenous prolein were calculated (24). 
ConlrWik protein sWdii. Adenosine triphosphate IATP). 
dilhiothreithol lDTT~.ethyknediamineteuaaceticacid(EDTA) 
and protealytic enzyme inhibitor (phenyl methyl sulfonyl Rue- 
ride IPMSFII were purchased from Sigma. Hear13 were stored 
at -80°C in 5% glycerol conmining 30 mM of potassium 
chloride (KCI). IO mM of paassium phosphate (K$0,) 
IpH 7.0). 2 rn,W of Dl-I and 0.2 mM of PMSF before the 
preparation of exwacts. Crude myosin tissue extracts for 
iscenzyme studies were obtained bv a sliehdv modified oroce- 
dure ok Mercadier et al. (25). Brietiy, 5Oio ia mg of c’wdiac 
tissue was homogenized in buffer A (Xl mM of KCI. IO m&f of 
K,PQ, 2 mM of magnesium chloride IMgCIJ. 0.5 mM of 
EDTA. 2 mM of DlTl with a Tekmar homoeenizer for 60 s. 
The homogenate was centrifuged al 3.W g fk 20 min at 4T. 
The pellet was washed WIO times) wilh the same buffer A and 
centrifuged. Subsequent extralion of crude myosin was done 
UsinE wroohosohate buffer11 ml: 4OmMofsodium ovmnhm- _.. 
phale (N&P& IpH 8.51. I’mM of EDTA. I mM ibti and 
0.1 mM of PMSF) for 4 h at 4°C. The tissue hom~emue was 
spun at I8 K for 25 min. The supxnatanl was mixed with an 
equal volume of cold glycerol and then stored at -70°C unlil 
ready forelectrophoretic studies. Fortheserwdies. the protein 
content of the enzyme was delcrmined by the Biuret method 
with bovine serum albumin as a amndard. Polyacrylamide gel 
electmohoresis [PAGE) of ovmohosohate exInxts was cer- 
formed on sodium dodecyi ;uifate iSLW gradiem IS& 10 
16.5%) slabs. Similar elecwmhoretic orofiles in contml and 
experimental gwps ruled oit [he possibility of proteolytic 
degradation and alm any missing or addilionai proleins by 
SDS-PAGE. 
,rm 1, wa, done hy polyacrylamidc gel cleclrophoreu~ using 
nondissociating condition\ a, ?‘C in II Pharmacis .rpp;waru\ 
(GE 214) as dercribed previou+ ,!hl. The run+ huk 
contamed 20 m&f Na,P,O, ,pH R.6). IW glycerol. I m,l 
EDTA and 0.01% ,volumeivolumc) 8.merc;~p,oe,h;mol Cy- 
lindrical 4% polyacrylamide gel\ I60 x 6 “ml *rre prepared 
airh ncrylamide and N.N’me,hylenc hir axylamidc 130. 
0.X). Approximately 5 ,o 6 pg of crude myorin curact was 
layered on each gel ??d run in a con~tim, volmgr gradx” of 
1.” volts/cm for 20 lo ?? h. The ccl> wcrc akxl ;and dclamcd 
and lheir dcn~ilometnc icnn\ were recorded on an E-C 
apparatus attached w a Hewlctl-Packard imegrator Imodel 
339U Al. The r&alive c\,ima,e of each ~wcnrymc ~a\ 
calculated from the area onder the pcik he&!. For Ihe 
calculalion of V, comen,. the VI iwenrymu wa, awm~cd to 
be equally distributed he,wecn V, and V, iro”yo\in 
Drug kvels. Approximately I ml of heparinized blood 
obtained a, the lime of mduced deah war cenrnfugcd ;md 
0.5 ml of plasma wa% promptly sepamed. wred m il glw 
vial and frozen in dry rice. Ssmplc\ fro” ,I% ml\ each m 
Groopr 2.3 and 4 and tbrcc ml\ in the conrrol group (Group 
51 were analyzed for plasma Icvel\ ofdilliarcm. U-dc\nelhgl 
diltiazem and dcsacetyl dd,wem hy Marion L;lbor;dorw 
wilh use of high preswre liqmd chromuoprophy Value\ 
helow the limits of derection were z~wpncd (t value of 0 for 
smlistlcal putpore\. 
SWislic-a, sna,jsic. Afrer ra,\ were a\\!,med ,o ,r~a,“cn, 
groups. ihere were 36 iit,\ in Gmup I, 38 m Croup 2. !? in 
Group 3. 38 in Group 4 and ?I m Group ?. .A ~o,al of Y rats 
were eliminated from anslyw. including 4 in Group I. 6 m 
Group 2. 9 in Group 3 and 4 in Group 4 rhn, wrc no, 
diabetic: 2 conlrol m,s [Group 5) u,i,h wru” glucwe con- 
cenlrarions in the diabelic more were idw excluded from 
aoalwis. Thw the orcwo, analysis include\ llala from 32 
ratsk~Group 1. 32 ii Group 2. ?b inCroup 3. 34 in Group4 
and I9 in Gmuo 5. A lolaI of I I hyperwnwe rat* (4 in Grout 
I. I in Group i. I in Group 3 endS in Group 41 died he&r; 
hload WBL~ obtained for “c;w~rc”en, of wu” glocorc. In 
Ihe prewn, analyrk. ,hew ra,s were conridcrcd 10 hc 
diabetic. A repam,e ;m;dy& (da,;~ no\ \houn, e~cludcd 
,heie m,s: conclusions were no, ~igmRc;mil~ ch;mprd. 
Sarvivrd curve analw~ wed the loz-rank ,c\,. S,ruc~uml 
dm;r were analyled u&e ,he chkqoxc IV\, IS ith Yaw\ 
corr~c,!on when npproprialel. ,911 of Ihc rr”;dninpdik~ wrc 
,n Group\ I to 4. hut ,hcrc wcrc no d,fference\ among my of 
rhew h~oer,cn\ne diabclic crooo\ Hean rme and hodv 
from that in comrol ra,\ (Group 5) dl th/\ lime m ,he \,ud). 
Ireetmen, dale ,Tab,c 2). SyMic blood prewarms and 
lhur, raw cIo\e 10 ,he lime of dealh ,rponraneou\ or dclib- 
ur~,,c) and m~,,:d ,wo” :lucoic concc”m,mn I~encnliy 
ohuned after the smr, of diltiarcm ,rea,mcntl arc siren m 
T.,hlr ?. Sywhc blood pre\\ure -raged abuu, 20 mm Hg 
hiahcr I” Ground I IO 4 than hefore .‘~d,“en, ,Tahlc 11. ho, 
there ncrc no d,“‘crcncc\ ;amon~ my 01 ,nc\e hyperwnsive 
dmhc,ic group\ Hcan raw !%a\ loner in each ofthe\e group, 
,h;m m ,hc comml group tGroup 5). There wa\ il &end IO a 
prognxivc dccrcwe m hear, ra!e m Group\ 2. 3 ;and 4. bu, 
none of the dnfferences amonp Group, I 10 4 were clittiui- 
ally ugmAc;mr. Serum glu~oce conccnlrafion nil* markedly 
clwated m Group< , ,o 4. but Ihere were no difference\ 
among ,he\c f<wr $roup\. 
control left ventricular weighl. Absolute right ventricular 
and lung weights (and lung waler) tended to be grealer in 
hypenenwe diabeuc rats than in control rats. but the 
ditTcrence* were not significant. In contrast. liver weight was 
markedly and equivalently increased in Groups I to 4. Left 
kidney weight was unchanged. but lhe right kidney doubled 
in weight in all hyperlensive diabetic groups. 
To control to xxne degree for the effects of decreased 
body weight in hypertensive diaheuc rats. relative organ 
weights were also determined (Table 41. Rclalive left and 
right venlricular weights were markedly increased in all 
hypertensive diabetic groups. There was a lrend lo a pro- 
gressive decrease in these weights in Groups 2.3 and 4. but 
none of the diffcrcnccs among Groups I lo 4 were ualisli- 
tally ~ignificam Relative lunc weight and lunp water were 
only aig.ificandy increased in&o&s I and 2 &pared with 
the conlrol group. Relative liver weight doubled in all 
hypertensive diabetic groups. 
Survival data. During the 4.monlh period afler assign- 
ment lo Ireaunent groups. mortalily r&r were 5% (Ifof 
32). 53% I I7 of 32). 27% 17 of 26). 35% II2 of 34) and 5% (I 
of 191 in Groups I, 2. 3. 4 and 5. respecwely (Fig. I). The 
marked and continuous increase in mollality rate in the 
untreated hypcnensive diabetic rats in Group I is apparent. 
Significant differences in survival were found comparing the 
lollowing pairs of groups: Groups I and 3. Groups I and 4. 
Groups I and 5. Groups 2 and 3. Groups 2 and 5 and Groups 
4 and 5. Mortality rates decreased by 54% and 41% in 
G:aups 3 and 4. respectively. compared with Group I. 
Survival in Group 3 was indistinguishable from lhat of 
age-matched control rats (Group 5). 
Pretreatment daln. Systolic blood pressure and heart rate 
tended to be higher and body weight lower in hypertensive 
diabetic ra1s lhai died versus thube that survived before 
dihiazem lreiwnem was started (data not shown). When all 
survivor!. are compared with all nonsurvivors in the byper- 
tensive diabetic groups (Groups I IO 4). blood pressure and 
heart rate were significantly higher in the rats that died: body 
weight differences were not significant (data not shown). 
Trealment dsla (Table 5). Systolic pressure in the hypw 
tensive diabetic groups (Groups I lo 4) was generally higher 
in rats that died. The differences between rats that died or 
survived were significant lor untreated rats and rats treated 
with 300 mg/kg per day of diltiazem. In each of the four 
Table 4. Final “at;,: Gr”“p Comparlronr 
hypertensive diahehc groroupr bear, rate aa~ vgnlcan~h 
higher in rats that died than m ,ho% that wrwcd: hart rate 
in those that died WBS no, s,a,isticQlly diffcrm, from tha, !n 
control ra,s (Group 9. Comparison of hean rate, hefore and 
during treatment ihowed ,ha, bear, rxe decbned over ,,mt 
in surviving rats but was eseendslly unchanged in hypeflen 
sive dnhetic rats ,hat died. eraggeenting rhe differmw 
between those ,ha, survived and thox that died. There wn 
no significant differences in serum glucotr conccn,rat~on 
between survivors and nonsurvivors I” rhe hgpertunirc 
diabolic groups. 
Find data. Body weights were markedly dccrcorcd in all 
groups of dying hypertensive diabetic rats compared t\i,h 
surviving rats (data no, shown). Absolute left and rifh, 
ventricular weigh& were similar in ~onwrvivori and wrvi- 
vors. Lung weigh, (and lung water) get,crW tended ,o he 
alive left vcntricolx weight was markedly and ~~gnibcaniy 
incrcaxd in nonsurvivon ven w survivors in the four hyper- 
len+e diabetic croup\. Compared with wIue< in age- 
matched control milts (Croup 51. relative left vcntricolar 
weight increnccd by >%I% and hy IW%. resprcdvely. in 
survivors and mnu;Yivor\ in Groufr I LO 4. Relative right 
ventr~ular wiShI ako lcndcd lo be ,:realer in rats that died 
than in those lhet survived. Thcec differences were not 
rrausrically ~ignificard. although relative riphl ventricular 
weight in nonsurvivor\ Ibut no1 in survivors) in Ihe hyper- 
Ietnive diabetic group\ wa greater than that in Ihe control 
group. Relative IunS weipht and lung waler were generally 
Sreatr in ra15 thal died than those that survived. With 
inclukm o;the Group I km&l that died after conclukw of 
Ihc morlality portion of the study among the nonsurvivors. 
rclalive lung weight and lung waler were alw aipnificandy 
greiller in nonsurvivors than survivor* in Group I. In con- 
hart. relative hmp welsh! and water did not differ signifi- 
candy between sowiving hypertensivr diabetic and control 
rats. Relative liver weight wils similar m survivon and 
nonsurvivors in all hypertensive diabetic groups. 
Survival data aerording lo initial blood pressure (Table 7). 
The obrervation that initial or final blood prabore was 
higher in nonsur~;?ors than in survivors amow the hvocr. 
tensive diabetic rats suggested that a separate analysi;‘can 
be performed on ra81~ in either the upper or Ihe lower half or 
the Sroup with respect 10 initial blood prcwre (the median 
initial sysrolic blood presrurc in hypertensive diabetic ran 
was 18” mm Hp). 
prnsw h I80 muz H,: II’~C rotnpnrrd wirb oar-aorchd 
wn/rol rm. There were no significant differences amonS 
hypene!lsive diabetic groups with respect IO initial or final 
blood pressure. although a trend lo a higher initial pressure 
in Group 3 (the smallest Smup) is apparent The mortality 
rate was very high in Groups I and 2. A significant decrease 
in mortalily was observed in Groups 3 and 4 compared with 
Group I 136% and 431. rerpcctively). 
Hyprrfnrriw din hrric rm wirh on inirinl syvrmk hbod 
~)rawrc ~180 w,n H# I~~TY alru ro~~~pm~d with rrp- 
aawhrd co,wr,l r(l,\. There were no differences among 
hypertensive diabetic Sroupr with respect 10 inilial or final 
blood ~~ressure. The mortalilv role of these rats in Gmun I 
wa:, &II significant. although <SOP/c of that in se&y 
hypertensive rats in Group I. The mortality rate in Gram 2 
wa\ aI50 greater than thai in age-matched~cnntrol rats. but 
the difference was of hordrrhne significance (0.05 < p < 
0.101. The mortality rate in Group% 3 and 4 was not Sreater 
than that in control rats and WBF 53% and 3f%. respccliveiy. 
lower :ban thal in Grow I. 
Slructurrl studiPs (Tables 8 and 9). With respect Io re. 
suits rr0nl the left vmide. the frequency 0r pcrivnscular 
fibrosis (grade 2). inlentitial fibrosis (grade3 I and 21 and 
vascular sclerosis @.rade~ 2 and 31 WBF sipnificanlly greater 
in nonsurvivor\ lhan in survivors in the total hypertensive 
diaklic cohort when the data from all nonsurvivors {and all 
survivors) were combined (data nor rhownl. Surviving 
hwertensive diabetic rafs were indisdnpui+tble from age- 
&itched control iaa. There was no &Ted of drug therapy on 
myocardial pathologic findings when only survivors (or only 
nonsurvivors) were compared. When rewlts from survivors 
and nonsurvivors in each group were combined. there WBZ a 
trend (not statistically significant) to lest per~vaccular A- 
brosis in Groups 2. 3 and 4 and less interstitial fibrosis in 
Groups 3 and 4 (Table 9). 
Ve,,,ricu,ar ccdlagen shldi~s (Table to,. There were no 
significant group difference> in ventriculx collagen concen- 
trations, although a trend to a progressive decrease in 
Gmups 2. 3 and 4 was observed. When survivor and 
nonsurvivor wbg:oups were anniyzcd. the collafen cancen- 
tration in nonsurvivors from Group 3 was higher than that in 
all other subgmups (except for ~onsurvivors from Group ?I. 
Comparison of all survivors and nonsurvivors in the byper- 
tensive diabetic cohort r&waled that collagen levels were 
significantly higher in the latter group (16.9 + 3.2 and 19.3 2 
3.8 pg collapofmg protein. respectivclyl. 
Contractik wrotein studies. All hypertensive diabehc 
groups had a markedly decreaed V, &y&n wfoorm coo- 
centration (I4 + 14.5%. 30.5 * l?.K~. 2.3 + 15%. 16.7 r 
16.3% and 93.5 ? 8.1% in Groups I to 5. rrspectivelyl. Rats 
in Group 2 had a V, concentration thot HOS greater than that 
in umremed mills tGroup I). but the difference IV;I\ of 
borderline statirticat sigmficance ~I.05 < p < 0.10). In 
cootmst. Group 3 and rspecially Gruup 4 rat\ had a V, 
concentration that ~.a very close to Ihat m untreated 
animals. To evaluate the influense ?I the severity ofdiabetes 
and hypertension on lhese resuIl& values for final worn 
glucose concentration and systolic blood pressure tin rats 
whose myosin level was studwil were computed (data not 
shownl. Serum fluco~ conce~wmu~~ MC lower m the 
subgroup of Group ! rat\ than m all other hypcrtenwe 
dubcrx rubgroups No significant ditTcrencc\ in \yclolic 
blood prexwre u ere found compxing h>pcrtenaive dmbcuc 
~a,\. although Groups ? and 4 tended to be m”re hypencn- 
\,re ,han Group\ 1 and 3. 
Plasma drui levels ,Taah(e I,,. Thsre we< B irend to a 
dose-related mcrease in the ptama iwet of ddriarsm and 
two of it\ mctaholiles in Group< ? 10 4. As expected. tewI\ 
were undetectable in ace-matched comrol rate (Group 0. In 
for ddruvem. N.desme:hg: diitiarcm and dcsacstyl dill- 
iilzcm. rc\pecllvrlyL 
‘The maior findinp of this study i> a greatly improved 
wrrwal r& m hyp&enrive diabetic rats treated with dill- 
mzem in the absence of any btuod prewre-laweriq effect. 
These results may have significant impiicatmw wttb rcryect 
to both rhe pathophyriology and lreatment of heart failure in 
human dmbetlc and hvpertenrive diabetic patients. 
Roteofh?pltenrion~~veri!y. Critical ~o~cvalualioo oithe 
results is lhc demonstration that untreated animals and each 
of the dihiarem ureatment groups were initially matched for 
blood pEC$Ure. hem, m,e and body weigh,. The panicutar 
tmponance of the severity of hypenenc+n war demon- 
htnied in sevenl ways in this cxperimem. es well as in 
another rccen! study (271. Rars rhs! died cponmneously were 
more hypenenrive than ~urwon and the mortality rate 
among rub wth severe hypeilension WBE much grealer than 
that II those with more modes! hvpenension. increased 
r&+twc left ventricular mass in by&eorive diabetic mts 
that died rcflcc~ at least in part. the greater systolic blood 
ptesure in these animals. Among hypertensive diabetic rats 
with a unlfornl degree of hyperglycemia. the wwily of associated wth pulmonary congestion. The relative lung 
hyperwvion IS probably the most important determinant of weight in rats thal died was greatly increased ovtr that in 
marlably. The beneficial elkls of dihiarem were grealest survivors. Increased relative right ventricular mass in hyper- 
(in absolute reducuon in morlality) m rat? with swcre tensive diabetic rats that died, bu1 not in those that survwed. 
hypertension. reflects. af least in pan. pulmonary congestion m the former 
Role of pulmonary congestion. Previous studies (8.27) as group. These relations were apparent in both dibiazem- 
well as the present one strongly suggest lhar mortality is treated and untreated rats. thus suggesting that improved 
survival in diltiazem-rreared ammnk I\ a reult of decrcawi 
pulmonary congestwt. which m turn rcRcct\ umprowd \p 
tolic or diastolic ventricular functicm. or both. 
Role of increased heart rate. Hcarl rm has heen pw- 
ously shown to decrease in diabetic rat:. l331. Rcccnt studlcs 
(13) demonstrate that thk increaw occurs in hypertenGvc 
diabetic rats as well. The present study confirm? this finding 
but also show that. Irrespective of treatment. heart rate 
during treatment is highcr in ncmwr~~v~~rs than ID FUVIYO~ 
among hypertensive diabetic rats. Although heart rate before 
the two hrgher doses. A progressive increase in plasma 
levels of ddGaem and two aclivc mctabolilei VW observed 
wilh increasing dew of diltinzem. Low or undetectable 
plasma levels were mesrured in the majority ofrats receivine 
the lowest dose of diltiazem. whrch may explain the absent; 
ofany significant cKcct of thib dose. The beneficial effects of 
the highir doses of dihiarem were demonstrated over a 
tv ofold range of dose,. 
If il is accepted that diltrazem in an appropriate dose 
prevents the development of systolic or diastolic wntricular 
dysfunction. or bolh. in hypertensive diabetic rats, the follow- 
ing mechanisms of action should be considered: I) antihyper- 
tensive effect. 2) direct prevention of rnyocyte necmsiP due to 
calcium overload. 3) anti-rschemic elTect. 41 direct prevention 
cl systohc venrricular dysfunction. and 5) direct prevention of 
diartohc vcntricul~~~ dysfunction. 
I. Decreased afterload. This would be expected to irnme- 
diately impmve systolic function. A sustained decrease in 
blood prersure should diminish ventricular hyperlraphy and 
improve coronary reserve: these long-term changes might 
lead to furlher improvement in systolic (and diastolic) ven- 
tricular function 129). The data from this study clearly 
demonstrate no effect ofdiltiarem on systolic blood pressure 
for left ventricular bypertropby) despite an improved mor- 
tality rate. Higher doses ofdiltiazem. which w&Id probably 
lower blood pressure. were not tolerated by hypertensive 
diabetic rats. probably reflecting their borderline cardiac 
function. 
1. Prevention of myoeyte necrosis and Bbmsia. Calcium 
channel blocker? have been shown to prevent myocyw 
necrosis in experm~ntal models of calcium overload. such 
as catecholamine necrosis, reperfusian injury and the hered- 
itary cardiomyopathy in Syrian hamsters (30-32). Pathologic 
data from the present study suggest but do not prove that 
diltiazsm decreased myocardial fibrosis. However. even if 
diltiazem prevenla myocyle necrosis and fibrosis I” hmer- 
tensive diabew rats. this might not account for the impr&ed 
surwal land decreased pulmonary congestion). This is 
supported by the small fracuon of the left ventricle mvolved 
by disease (that IS. fibrosis) in a recent quantitative study 
127) ofthis model (2.39% m rats that died rpontaneourly~ and 
the absence of any change m rnyocardial collagen corrccn- 
tration in the present study (comparing untreated hyperten- 
sive diabetic and control rate). The latter observation sug- 
gests that growth of myocardial connective tissue is nearly 
proportional to myocyte typertrophy in t’lis model (331. Tw 
increased collagen concentration in hypertensive diabetic 
rats that died compared with that in tbosc that survived was 
significant (wpporting the microscopic findings), but modest 
in magnitude. It is uncertain. therefore. whether myacardial 
disease in this model ib an epiphenomenon (correlating in 
part with the magnitude of hyperiensionl or, coupled with 
funclional alterations in the viable myocardium. does have a 
major effect on cardiac performance and survival. 
3. Anti-ischemic erect of diltiazem. This could improve 
myocardial function in several ways: I) prevention of myo- 
cyte necrosis, and 21 improved systolic and diastolic func- 
tion in the viable myocardium. Mechanisms of an anti-lsch- 
emit effect could include: I) decreased systolic blood 
pre~ure. 2) decreased heart rate. 3) decreased contractility, 
and 4) increased coronary blood flow. The present study 
provides no wpport for the first two possibilities. Decreased 
contractility would seem an unlikely explanation for an 
ultimate improvement in systolic function but might, by an 
anti-iachemic effect, accounl for an ultimate improvement in 
diastohc function. No data are yet available to support 
improved coronary blood Row with diltiazem in hyperten- 
sive diabetic rats. 
4 and 5. Direct prevention of ventricular dysfunction. 
Diltiazem could reverse some of the alterations in cellular 
dysfunction that are a consequence of diabetes. Afzal et al. 
f20.21) recently showed that in viva hernodynamics Ileft 
ventricular systolic pressure and pak rate of increase and 
decrease in left ventricular pressure) and myocardial bio- 
chemistry (myofibrillar and myosin adenosine triphos- 
phataees. myosin isoenzyme distribution and sarcopl&mic 
reticular calcium transport and adenosine triphosphatase) 
were significantly improved in diabetic rats treated with 
veropamil. These findings were interpreted as support for the 
hypothesis that increased myocardial cuium may lead to 
systolic (mechanism 4) and diastolic (mechanism 5) ventric- 
ular dysfunction characteristic of the diabetic heart. The 
only data from the present study that directly bear on these 
considerations are the myosin isoen’yme Wdies. The pm- 
found decrease in V, conccntralion in hwertensive diabetic 
rats has been prewobsly described (13):The clinical benefit 
of diltiazem in hypertensive diabetic rats war not aerocialed 
with reversal of the altered myosin isoenzyme distribution 
fin Groups 3 and 4). The possibility remains. however, that 
other cellular adaptations to diabetes. such as altered sarco- 
plasmic reticular function, may be rcvcrsed by diltisrem 
treatment of hypertensive diabetic animals. 
Clinical implications. Further studies are necdcd to clar- 
ify the role of diltiarem in hypertensive diabetic cardiomy- 
opalhy. They include the following da&a in treated and 
untreated animals: I) myocardial calcium. 2) coronary Row 
,hrillm<C 
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